Sophiris Bio's Stock More Than Doubles After Prostate Cancer Treatment's Successful Test Results 0 10.06.2016 15:13 «FOX Business» (foxbusiness.com) Shares of Sophiris Bio Inc. more than doubled in active premarket trade Friday, after the biotechnology company announced positive results from a study of its prostate cancer treatment. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
